Skip to main content
. 2025 Dec 4;15(23):3086. doi: 10.3390/diagnostics15233086
2D-GE Two-dimensional gel electrophoresis
CAFs Cancer-associated fibroblasts
CE-MS Capillary electrophoresis–mass spectrometry
DIA Data-independent acquisition
DMFS Decayed, missing, and filled surfaces
EMT Epithelial–mesenchymal transition
EVs Extracellular vesicles
GC-MS Gas chromatography-mass spectrometry
GCF Gingival crevicular fluid
GWAS Genome-wide association study(s)
iTRAQ Isobaric tags for relative and absolute quantitation
LC-MS/MS Liquid chromatography coupled to tandem mass spectrometry
LFQ Label-free quantification
lncRNA Long non-coding RNA
MDSCs Myeloid-derived suppressor cells
miRNA MicroRNA
MMPg Mucous membrane pemphigoid
mRNA Messenger RNA
MS Mass spectrometry
NGS Next-generation sequencing
NMR Nuclear magnetic resonance
OSCC Oral squamous cell carcinoma
p-EMT Partial epithelial–mesenchymal transition
PCA Principal component analysis
PLS-DA Partial least squares discriminant analysis
PRS Polygenic risk score
PV Pemphigus vulgaris
RNA-seq RNA sequencing
SCFAs Short-chain fatty acids
scRNA-seq Single-cell RNA sequencing
SS Sjögren’s syndrome
SWATH-MS Sequential window acquisition of all theoretical mass spectra
TCA Tricarboxylic acid cycle
TILs Tumor-infiltrating lymphocytes
TME Tumor microenvironment
TMT Tandem mass tags
UPLC-MS Ultra-performance liquid chromatography-mass spectrometry
WES Whole-exome sequencing